Stemming an Epidemic

Robert Hogg focuses on identifying ongoing health inequities among vulnerable HIV-positive populations to better meet their unique health care needs.

Since the early 1990s, SFU professor of health sciences Dr. Robert Hogg has been conducting demographic research on British Columbia’s HIV-positive population. With an eye towards influencing health policy decisions and improving health outcomes, his work has earned him an international reputation as a leading population health researcher.

More recently, Hogg’s focus has turned to analyzing health trends among marginalized HIV-positive groups. For instance, Hogg was senior author on a first-of-its-kind study which found that food insecurity increases the risk of death among injection drug users living with HIV/AIDS. He also investigates how access to antiretroviral therapy (ART) influences sexual practice and infection rates among men who have sex with men, and examines how the treatment affects HIV-positive individuals who suffer from age-related diseases such as cancer. The latter is significant as more than half of all HIV-positive individuals in North America are over the age of 50. The findings will help create new strategies to meet the unique needs of these populations.

The Canadian Institutes of Health Research has recognized the importance of Hogg’s work by awarding him with multi-million dollar grants. This includes $2.7 million awarded in 2014 towards the Canadian HIV Observational Cohort (CANOC), the country’s only longitudinal study of more than 10,000 people undergoing antiretroviral therapy in Canada. It also helped him establish the CANOC Collaborative Research Centre which will allow a large team of researchers to continue tracking Canada’s HIV-positive population and further contribute to the understanding of challenges presented by HIV.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below